National Health Investors, Inc. (NHI) Earnings Call Transcripts

28 earnings calls from February 2020 to August 11, 2026

NYSE US Real Estate Health Care REITs

National Health Investors, Inc.'s Latest Earnings Call - Q1 FY2026

In the first quarter of 2026, National Health Investors, Inc. (NHI) reported strong results, with NAREIT FFO per share increasing by 7.9% to $1.23, driven by robust portfolio performance and strategic investments. However, management updated its full-year guidance, anticipating a decrease in FFO due to the pending $560 million sale of the NHC portfolio, which is expected to create near-term earnings pressure. Despite this, the company remains optimistic about its long-term growth trajectory, particularly within its SHOP portfolio, which is projected to contribute significantly to future revenue streams.

Reported metrics

MetricValueContext
NAREIT FFO per Share $1.23 (beat) up 7.9% YoY
Net Income per Share $0.82 (beat) up 10.8% YoY
Total SHOP NOI Growth 188.1% (beat) compared to Q1 2025
Same-Store NOI Growth 1% to 3% (negative) revised full-year guidance
Cash Lease Revenue Growth 7.7% (positive) year-over-year
Average NOI Yield on New Investments 7.8% (inline) expected for future investments

Guidance from management

NHI expects GAAP net income at the midpoint to be $14.37 per share and anticipates NAREIT FFO and NFFO per share to be $4.77, reflecting a 2.6% increase and a 2.9% decrease, respectively, compared to 2025. The guidance includes $180 million in additional future investments.

What management said

Juan, this is Eric. I'll take that question. If a third-party reaches out in writing, then we will issue a press release about that. Until then, we're not ready to disclose anything.
— D. Mendelsohn, Q1 FY2026 earnings call
Sure. I would suggest to you that the market is very competitive. So we're trying to meet the market and make sure that we're making good decisions based on data and that we understand the markets that we're going into and what our operators' competencies are as they manage these assets and finding the right fit between the 2. So I think our underwriting has evolved over time, and I feel confident in our ability to e...
— Kevin Pascoe, Q1 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the underperformance of the legacy Holiday properties and the impact of the NHC sale on future earnings. There were questions about the timeline for redeploying capital from the NHC sale and the potential for a special dividend due to capital gains.

Main topics on the call

Read the full National Health Investors, Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About National Health Investors, Inc.

National Health Investors, Inc. (NHI) is a publicly listed company in the Health Care REITs industry, within the Real Estate sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 28 calls on record spanning February 19, 2020 to August 11, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 28 National Health Investors, Inc. earnings call transcripts on record, spanning February 19, 2020 to August 11, 2026. Based on this history, National Health Investors, Inc. reports quarterly. The most recent call on file is dated August 11, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
NHI
Exchange
NYSE
Country
US
Sector
Real Estate
Industry
Health Care REITs
Calls on record
28
First call
February 19, 2020
Most recent
August 11, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 11, 2026 Read transcript
Q1 FY2026 May 5, 2026 Read transcript
Q4 FY2025 Feb 27, 2026 Read transcript
Q3 FY2025 Nov 7, 2025 Read transcript
Q2 FY2025 Aug 7, 2025 Read transcript
Q4 FY2024 Feb 26, 2025 Read transcript
Q3 FY2024 Nov 6, 2024 Read transcript
Q2 FY2024 Aug 7, 2024 Read transcript
Q1 FY2024 May 7, 2024 Read transcript
Q4 FY2023 Feb 21, 2024 Read transcript
Q3 FY2023 Nov 8, 2023 Read transcript
Q2 FY2023 Aug 9, 2023 Read transcript
Q1 FY2023 May 10, 2023 Read transcript
Q4 FY2022 Feb 22, 2023 Read transcript
Q3 FY2022 Nov 9, 2022 Read transcript
Q2 FY2022 Aug 9, 2022 Read transcript
Q1 FY2022 May 10, 2022 Read transcript
Q4 FY2021 Feb 23, 2022 Read transcript
Q3 FY2021 Nov 8, 2021 Read transcript
Q2 FY2021 Aug 10, 2021 Read transcript
Q1 FY2021 May 11, 2021 Read transcript
Shareholder/Analyst Calls May 4, 2021 Read transcript
Q4 FY2020 Feb 23, 2021 Read transcript
Q3 FY2020 Nov 10, 2020 Read transcript
Q2 FY2020 Aug 11, 2020 Read transcript
Q1 FY2020 May 12, 2020 Read transcript
Shareholder/Analyst Calls May 6, 2020 Read transcript
Q4 FY2019 Feb 19, 2020 Read transcript